New CDC Recommendations for Immunocompromised Patients

Your health is very important to us! Please consider the latest CDC recommendations for immunocompromised patients.

Patients taking medications including Remicade, Humira, Entyvio, Cimzia, Stelara and Xeljanz are considered immunocompromised.

People with moderately to severely compromised immune systems are especially vulnerable to COVID-19 and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised.

CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine at least 28 days after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.

For more information, please visit https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html

If you have any questions, please feel free to contact us directly at at 414-908-6500.